U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07801391) titled 'Personalized and Accelerated Transcranial Magnetic Stimulation for Treatment-resistant Anxiety Related Disorders' on Aug. 31.
Brief Summary: This proposal seeks to carry out an open-label single arm study to examine the neurobehavioral changes induced by personalized, causal network mapping guided accelerated intermittent theta burst stimulation (aiTBS) in patients with treatment-resistant anxiety-related disorders.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Anxiety and Fear-Related Disorders
Intervention:
DEVICE: Individually Neuronavigated accelerated intermittent theta burst stimulation with MagPro ...